NeoGenomics (NEO) Set to Announce Quarterly Earnings on Tuesday

NeoGenomics (NASDAQ:NEO) is scheduled to be releasing its earnings data before the market opens on Tuesday, November 5th. Analysts expect NeoGenomics to post earnings of $0.01 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

NeoGenomics Stock Up 3.0 %

Shares of NASDAQ:NEO opened at $14.00 on Friday. The company has a market capitalization of $1.79 billion, a P/E ratio of -22.58 and a beta of 1.19. The stock’s fifty day simple moving average is $14.80 and its 200-day simple moving average is $14.70. NeoGenomics has a 52-week low of $12.77 and a 52-week high of $21.22. The company has a quick ratio of 1.93, a current ratio of 2.01 and a debt-to-equity ratio of 0.37.

Analyst Upgrades and Downgrades

NEO has been the subject of several recent research reports. Needham & Company LLC reissued a “buy” rating and issued a $19.00 price objective on shares of NeoGenomics in a research report on Wednesday, September 25th. Benchmark reiterated a “buy” rating and issued a $18.00 price target on shares of NeoGenomics in a report on Tuesday, September 24th. Finally, Stephens restated an “overweight” rating and set a $19.00 price objective on shares of NeoGenomics in a research note on Tuesday, July 30th. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.89.

About NeoGenomics

NeoGenomics, Inc operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.